nach oben

Journal of Assisted Reproduction and Genetics

Erschienen in:

13.07.2018 | Assisted Reproduction Technologies

Decision making processes of women who seek elective oocyte cryopreservation

verfasst von: Ran Kim, Tae Ki Yoon, Inn Soo Kang, Mi Kyoung Koong, Yoo Shin Kim, Myung Joo Kim, Yubin Lee, Jayeon Kim

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study is to analyze women’s opinions and their decision making processes regarding elective oocyte cryopreservation (OC).

Methods

One hundred twenty-four women who had elective OC counseling at the CHA Seoul Fertility Center were asked to complete a survey after their first visit. Data collection regarding age, marital status, monthly income, occupation, religion, reproductive history, questions about the participant’s view on their own fecundity, and future parenthood were included. The modified Reproductive Concerns After Cancer scale and the Decisional Conflict Scale were used for analysis.

Results

The participants’ mean age was 37.1 ± 4.8 years old. Eighty-six percent of the participants had regular periods. Ninety-two percent thought it was important to have their own biological offspring, and 86% were willing to pursue OC. Forty-nine percent appeared to have high DCS scores regarding making a decision of OC. Sixty-eight percent pursued OC, and the mean number of oocytes cryopreserved per patient was 10.5 ± 8.3. Multivariate analysis revealed that age was the only factor associated with high DCS scores (P = 0.002). Feeling less fertile than other women of same age and low DCS scores were the factors associated with pursuing OC (P = 0.02 and 0.004, respectively) after adjusting for possible confounding factors, including age.

Conclusions

Older women had more difficulties in making decisions about OC. Adjusting for age, women who thought that they were less fertile than other women of same age and those with lower decisional conflict were more likely to pursue OC. Further studies should focus on the validation of older women’s decisional conflicts regarding OC.

Nur mit Berechtigung zugänglich

Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011;96(2):277–85. https://doi.org/10.1016/j.fertnstert.2011.06.030.CrossRefPubMed

Cobo A, Coello A, Remohi J, Serrano J, de Los Santos JM, Meseguer M. Effect of oocyte vitrification on embryo quality: time-lapse analysis and morphokinetic evaluation. Fertil Steril. 2017;108(3):491–7 e3. https://doi.org/10.1016/j.fertnstert.2017.06.024.CrossRefPubMed

Practice Committees of American Society for Reproductive M, Society for Assisted Reproductive T. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99(1):37–43. https://doi.org/10.1016/j.fertnstert.2012.09.028. CrossRef

KOSTAT. 2017. http://kostat.go.kr/portal/korea/kor_nw/2/2/1/index.board?bmode=read&bSeq=&aSeq=366414&pageNo=1&rowNum=10&navCount=10&currPg=&sTarget=title&sTxt=.

Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1(8486):884–6.CrossRefPubMed

Argyle CE, Harper JC, Davies MC. Oocyte cryopreservation: where are we now. Hum Reprod Update. 2016;22(4):440–9. https://doi.org/10.1093/humupd/dmw007.CrossRefPubMed

Schattman GL. CLINICAL PRACTICE. Cryopreservation of oocytes. N Engl J Med. 2015;373(18):1755–60. https://doi.org/10.1056/NEJMcp1307341. CrossRefPubMed

Papatheodorou A, Vanderzwalmen P, Panagiotidis Y, Petousis S, Gullo G, Kasapi E, et al. How does closed system vitrification of human oocytes affect the clinical outcome? A prospective, observational, cohort, noninferiority trial in an oocyte donation program. Fertil Steril. 2016;106(6):1348–55. https://doi.org/10.1016/j.fertnstert.2016.07.1066.CrossRefPubMed

De Munck N, Belva F, Van de Velde H, Verheyen G, Stoop D. Closed oocyte vitrification and storage in an oocyte donation programme: obstetric and neonatal outcome. Hum Reprod. 2016;31(5):1024–33. https://doi.org/10.1093/humrep/dew029.CrossRefPubMed

10.

Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril. 2016;105(2):459–66 e2. https://doi.org/10.1016/j.fertnstert.2015.10.026.CrossRefPubMed

11.

Potdar N, Gelbaya TA, Nardo LG. Oocyte vitrification in the 21st century and post-warming fertility outcomes: a systematic review and meta-analysis. Reprod BioMed Online. 2014;29(2):159–76. https://doi.org/10.1016/j.rbmo.2014.03.024.CrossRefPubMed

12.

Levi-Setti PE, Borini A, Patrizio P, Bolli S, Vigiliano V, De Luca R, et al. ART results with frozen oocytes: data from the Italian ART registry (2005-2013). J Assist Reprod Genet. 2016;33(1):123–8. https://doi.org/10.1007/s10815-015-0629-5.CrossRefPubMed

13.

Cobo A, Serra V, Garrido N, Olmo I, Pellicer A, Remohi J. Obstetric and perinatal outcome of babies born from vitrified oocytes. Fertil Steril. 2014;102(4):1006–15 e4. https://doi.org/10.1016/j.fertnstert.2014.06.019.CrossRefPubMed

14.

O’Connor AM. Validation of a decisional conflict scale. Med Decis Mak. 1995;15(1):25–30.CrossRef

15.

Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;10:CD001431. https://doi.org/10.1002/14651858.CD001431.pub3.CrossRef

16.

Ethics ETFo, Law, Dondorp W, de Wert G, Pennings G, Shenfield F, et al. Oocyte cryopreservation for age-related fertility loss. Hum Reprod. 2012;27(5):1231–7. https://doi.org/10.1093/humrep/des029.CrossRef

17.

Hammarberg K, Kirkman M, Pritchard N, Hickey M, Peate M, McBain J, et al. Reproductive experiences of women who cryopreserved oocytes for non-medical reasons. Hum Reprod. 2017;32(3):575–81. https://doi.org/10.1093/humrep/dew342. PubMedCrossRef

18.

Milman LW, Senapati S, Sammel MD, Cameron KD, Gracia C. Assessing reproductive choices of women and the likelihood of oocyte cryopreservation in the era of elective oocyte freezing. Fertil Steril. 2017;107(5):1214–22 e3. https://doi.org/10.1016/j.fertnstert.2017.03.010.CrossRefPubMedPubMedCentral

19.

Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer. 2009;53(2):281–4. https://doi.org/10.1002/pbc.22001.CrossRefPubMed

20.

Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N. What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility. Fertil Steril. 2013;100(5):1343–9. https://doi.org/10.1016/j.fertnstert.2013.07.201.CrossRefPubMed

21.

Stoop D, Maes E, Polyzos NP, Verheyen G, Tournaye H, Nekkebroeck J. Does oocyte banking for anticipated gamete exhaustion influence future relational and reproductive choices? A follow-up of bankers and non-bankers. Hum Reprod. 2015;30(2):338–44. https://doi.org/10.1093/humrep/deu317.CrossRefPubMed

22.

Ter Keurst A, Boivin J, Gameiro S. Women’s intentions to use fertility preservation to prevent age-related fertility decline. Reprod BioMed Online. 2016;32(1):121–31. https://doi.org/10.1016/j.rbmo.2015.10.007.CrossRefPubMed

23.

Lallemant C, Vassard D, Nyboe Andersen A, Schmidt L, Macklon N. Medical and social egg freezing: internet-based survey of knowledge and attitudes among women in Denmark and the UK. Acta Obstet Gynecol Scand. 2016;95(12):1402–10. https://doi.org/10.1111/aogs.13024.CrossRefPubMed

24.

Gorman JR, Su HI, Pierce JP, Roberts SC, Dominick SA, Malcarne VL. A multidimensional scale to measure the reproductive concerns of young adult female cancer survivors. J Cancer Surviv. 2014;8(2):218–28. https://doi.org/10.1007/s11764-013-0333-3. CrossRefPubMed

25.

Benedict C, Thom B, Friedman DN, Diotallevi D, Pottenger EM, Raghunathan NJ, et al. Young adult female cancer survivors’ unmet information needs and reproductive concerns contribute to decisional conflict regarding posttreatment fertility preservation. Cancer. 2016;122(13):2101–9. https://doi.org/10.1002/cncr.29917.CrossRefPubMed

26.

Li F, Chen G, Sheng C, Gusdon AM, Huang Y, Lv Z, et al. BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis. Endocr Relat Cancer. 2015;22(2):159–68. https://doi.org/10.1530/ERC-14-0531.CrossRefPubMedPubMedCentral

27.

Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril. 2013;100(2):492–9 e3. https://doi.org/10.1016/j.fertnstert.2013.04.023.CrossRefPubMedPubMedCentral

28.

Chang CC, Elliott TA, Wright G, Shapiro DB, Toledo AA, Nagy ZP. Prospective controlled study to evaluate laboratory and clinical outcomes of oocyte vitrification obtained in in vitro fertilization patients aged 30 to 39 years. Fertil Steril. 2013;99(7):1891–7. https://doi.org/10.1016/j.fertnstert.2013.02.008.CrossRefPubMed

29.

Cobo A, Garrido N, Pellicer A, Remohi J. Six years’ experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil Steril. 2015;104(6):1426–34 e1-8. https://doi.org/10.1016/j.fertnstert.2015.08.020.CrossRefPubMed

30.

Battaglia DE, Goodwin P, Klein NA, Soules MR. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod. 1996;11(10):2217–22.CrossRefPubMed

31.

Rudick B, Opper N, Paulson R, Bendikson K, Chung K. The status of oocyte cryopreservation in the United States. Fertil Steril. 2010;94(7):2642–6. https://doi.org/10.1016/j.fertnstert.2010.04.079.CrossRefPubMed

32.

Gorman JR, Malcarne VL, Roesch SC, Madlensky L, Pierce JP. Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns. Breast Cancer Res Treat. 2010;123(2):477–85. https://doi.org/10.1007/s10549-010-0768-4.CrossRefPubMedPubMedCentral

33.

Baldwin K, Culley L, Hudson N, Mitchell H, Lavery S. Oocyte cryopreservation for social reasons: demographic profile and disposal intentions of UK users. Reprod BioMed Online. 2015;31(2):239–45. https://doi.org/10.1016/j.rbmo.2015.04.010.CrossRefPubMed

34.

O’Connor AM, Jacobsen MJ, Stacey D. An evidence-based approach to managing women’s decisional conflict. J Obstet Gynecol Neonatal Nurs. 2002;31(5):570–81.CrossRefPubMed

Titel: Decision making processes of women who seek elective oocyte cryopreservation
verfasst von: Ran Kim
Tae Ki Yoon
Inn Soo Kang
Mi Kyoung Koong
Yoo Shin Kim
Myung Joo Kim
Yubin Lee
Jayeon Kim
Publikationsdatum: 13.07.2018
Verlag: Springer US
Erschienen in: Journal of Assisted Reproduction and Genetics / Ausgabe 9/2018
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-018-1255-9

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

Prämenstruelle Beschwerden mit Suizidrisiko assoziiert

04.06.2024 Suizidalität Nachrichten

Manche Frauen, die regelmäßig psychische und körperliche Symptome vor ihrer Menstruation erleben, haben ein deutlich erhöhtes Suizidrisiko. Jüngere Frauen sind besonders gefährdet.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Decision making processes of women who seek elective oocyte cryopreservation